What is NDC 17856-0691?

17856-0691 is the product NDC for Ondansetron, Ondansetron hydrochloride 4 mg/5mL solution, listed with the FDA by ATLANTIC BIOLOGICALS CORP.. It has 7 package NDCs, shown above in 10- and 11-digit form.

ATLANTIC BIOLOGICALS CORP., NDC labeler code 17856. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ondansetron?

190 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ondansetron NDC 17856-0691 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)17856-0691Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17856-0691Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
17856-0691-1	1785606910117856069101	1.5 mL in 1 SYRINGE (17856-0691-1)Marketed from Apr 17, 2024
17856-0691-2	1785606910217856069102	2.5 mL in 1 SYRINGE, PLASTIC (17856-0691-2)Marketed from Apr 17, 2024
17856-0691-4	1785606910417856069104	2.5 mL in 1 SYRINGE, PLASTIC (17856-0691-4)Marketed from Apr 17, 2024
17856-0691-5	1785606910517856069105	5 mL in 1 CUP (17856-0691-5)Marketed from Apr 17, 2024
17856-0691-6	1785606910617856069106	120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-6) / 1.25 mL in 1 SYRINGEMarketed from Apr 17, 2024
17856-0691-7	1785606910717856069107	48 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-7) / 1.9 mL in 1 SYRINGEMarketed from Apr 17, 2024
17856-0691-8	1785606910817856069108	60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-8) / 2.5 mL in 1 SYRINGEMarketed from Apr 17, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ondansetron
Generic name (nonproprietary): ondansetron
Active ingredients: Ondansetron hydrochloride — 4 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: ATLANTIC BIOLOGICALS CORP.NDC labeler code 17856
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091483
Marketing start: Dec 17, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 3 Receptor Antagonists (Mechanism)
Identifiers: Product ID 17856-0691_3633ef65-d53d-4728-e063-6394a90a6205SPL ID 3633ef65-d53d-4728-e063-6394a90a6205SPL set ID e5ab38a2-5921-4320-a313-e0080c078046RxCUI 312085UNII NMH84OZK2B
Pharmacologic class: Serotonin-3 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417856069101 followed by a unit qualifier and the quantity

Package 17856-0691-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 28, 2025.

Indications (excerpt from the label)

Ondansetron oral solution is indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . initial and repeat courses of moderately emetogenic cancer chemotherapy. radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. Ondansetron oral solution is a 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . (1) nausea and vomiting associated with initial and repeat courses …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 17856-0691

What is NDC 17856-0691?: 17856-0691 is the product NDC for Ondansetron, Ondansetron hydrochloride 4 mg/5mL solution, listed with the FDA by ATLANTIC BIOLOGICALS CORP.. It has 7 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ondansetron.
What is the active ingredient?: Ondansetron hydrochloride.
Who is the labeler?: ATLANTIC BIOLOGICALS CORP., NDC labeler code 17856. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ondansetron?: 190 other product NDCs are listed under this name. See all Ondansetron NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ondansetron NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	REMEDYREPACK INC.	70518-4685	70518-4685-00
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	Preferred Pharmaceuticals Inc.	68788-4133	68788-4133-0168788-4133-03
Ondansetron	Ondansetron hydrochloride 4 mg/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-4882	00121-4882-94
Ondansetron	Ondansetron hydrochloride 4 mg/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-0882	00121-0882-51
Ondansetron	Ondansetron hydrochloride 2 mg/mL	InjectionIntramuscular, Intravenous	JVET PHARMACEUTICALS LLC	86211-115	86211-0115-01
Ondansetron	Ondansetron hydrochloride 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-4588	70518-4588-00
Ondansetron	Ondansetron hydrochloride 2 mg/mL	Injection, SolutionIntramuscular, Intravenous	Hospira, Inc.	0409-2271	00409-2271-25
Ondansetron	Ondansetron 4 mg/1	Tablet, Orally disintegratingOral	AvKARE	42291-457	42291-0457-30
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	AvKARE	42291-458	42291-0458-30
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	St. Mary's Medical Park Pharmacy	60760-936	60760-0936-10

All 191 Ondansetron NDCs

Other NDCs under ANDA 091483

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091483
Product	Strength	Form · route	Labeler	Product NDC
Ondansetron	Ondansetron hydrochloride 4 mg/5mL	SolutionOral	AvPAK	50268-647
Ondansetron	Ondansetron hydrochloride 4 mg/5mL	SolutionOral	American Health Packaging	60687-252
Ondansetron	Ondansetron hydrochloride 4 mg/5mL	SolutionOral	Amneal Pharmaceuticals LLC	65162-691